HEADER SIGNALING PROTEIN 12-OCT-01 1K5R TITLE YAP65 WW DOMAIN S24-AMINO-ETHYLSULFANYL-ACETIC ACID MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: 65 KDA YES-ASSOCIATED PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: WW DOMAIN, RESIDUES 5-44; COMPND 5 SYNONYM: YAP65; YES-ASSOCIATED PROTEIN 65 KDA; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: 40-PEPTIDE CONSTRUCT WITH SYNTHETIC AMINO-ETHYL- COMPND 9 SULFANYL-ACETIC ACID LINK AT POSITION 24; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: FRAGMENT OF WBP-1; COMPND 12 CHAIN: B; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE SEQUENCE OCCURS NATURALLY IN HUMANS; SOURCE 4 MOL_ID: 2; SOURCE 5 SYNTHETIC: YES; SOURCE 6 OTHER_DETAILS: THE SEQUENCE OCCURS NATURALLY IN HUMANS KEYWDS WW DOMAIN, YAP65, BETA-SHEET PROTEINS, STABILITY OF BETA SHEETS, KEYWDS 2 SIGNALING PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR N.FERGUSON,J.R.PIRES,F.TOEPERT,C.M.JOHNSON,Y.P.PAN,R.VOLKMER-ENGERT, AUTHOR 2 J.SCHNEIDER-MERGENER,V.DAGGETT,H.OSCHKINAT,A.R.FERSHT REVDAT 5 15-NOV-23 1K5R 1 LINK ATOM REVDAT 4 23-FEB-22 1K5R 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1K5R 1 VERSN REVDAT 2 30-SEP-03 1K5R 1 JRNL DBREF REVDAT 1 02-NOV-01 1K5R 0 JRNL AUTH N.FERGUSON,J.R.PIRES,F.TOEPERT,C.M.JOHNSON,Y.P.PAN, JRNL AUTH 2 R.VOLKMER-ENGERT,J.SCHNEIDER-MERGENER,V.DAGGETT,H.OSCHKINAT, JRNL AUTH 3 A.FERSHT JRNL TITL USING FLEXIBLE LOOP MIMETICS TO EXTEND PHI-VALUE ANALYSIS TO JRNL TITL 2 SECONDARY STRUCTURE INTERACTIONS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 13008 2001 JRNL REFN ISSN 0027-8424 JRNL PMID 11687614 JRNL DOI 10.1073/PNAS.221467398 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 2.6, X-PLOR 3.1 REMARK 3 AUTHORS : BRUKER (XWINNMR), BRUNGER, A.T. (X-PLOR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 2000K, 200 RUNS, FORCE CONSTANTS FOR REMARK 3 NOE 50 KCALMOL-1RAD-2, 590 RESTRAINTS REMARK 4 REMARK 4 1K5R COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-OCT-01. REMARK 100 THE DEPOSITION ID IS D_1000014594. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288; 288 REMARK 210 PH : 6; 6 REMARK 210 IONIC STRENGTH : 100 MM NACL; 100 MM NACL REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : PHOSPHATE BUFFER 10 MM, NACL REMARK 210 100MM, DTT 0.1MM, EDTA 0.1 MM, REMARK 210 PH 6, WW DOMAIN 1.2 MM LIGAND REMARK 210 2.4 MM; PHOSPHATE BUFFER 10 MM, REMARK 210 NACL 100MM, DTT 0.1MM, EDTA 0.1 REMARK 210 MM, PH 6 WW DOMAIN, 1.2 MM REMARK 210 LIGAND 2.4 MM REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ANSIG 3.3 REMARK 210 METHOD USED : SIMULATED ANNELING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 45 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JMQ RELATED DB: PDB REMARK 900 RELATED ID: 1EOM RELATED DB: PDB REMARK 900 RELATED ID: 1EG3 RELATED DB: PDB REMARK 900 RELATED ID: 1EG4 RELATED DB: PDB REMARK 900 RELATED ID: 1I5H RELATED DB: PDB DBREF 1K5R A 5 44 UNP P46937 YAP1_HUMAN 165 204 DBREF 1K5R B 45 54 PDB 1K5R 1K5R 45 54 SEQADV 1K5R ESD A 24 UNP P46937 SER 184 MODIFIED RESIDUE SEQRES 1 A 41 PHE GLU ILE PRO ASP ASP VAL PRO LEU PRO ALA GLY TRP SEQRES 2 A 41 GLU MET ALA LYS THR SER ESD GLY GLN ARG TYR PHE LEU SEQRES 3 A 41 ASN HIS ILE ASP GLN THR THR THR TRP GLN ASP PRO ARG SEQRES 4 A 41 LYS NH2 SEQRES 1 B 10 GLY THR PRO PRO PRO PRO TYR THR VAL GLY HET ESD A 24 14 HET NH2 A 45 3 HETNAM ESD (2-AMINO-ETHYLSULFANYL)-ACETIC ACID HETNAM NH2 AMINO GROUP FORMUL 1 ESD C4 H9 N O2 S FORMUL 1 NH2 H2 N SHEET 1 A 3 TRP A 17 THR A 22 0 SHEET 2 A 3 GLN A 26 ASN A 31 -1 N TYR A 28 O ALA A 20 SHEET 3 A 3 THR A 36 THR A 38 -1 N THR A 37 O LEU A 30 LINK C SER A 23 N ESD A 24 1555 1555 1.31 LINK C ESD A 24 N GLY A 25 1555 1555 1.31 LINK C LYS A 44 N NH2 A 45 1555 1555 1.30 CISPEP 1 SER A 23 ESD A 24 6 3.35 SITE 1 AC1 1 LYS A 44 CRYST1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1